Stricter compliance procedures eyed by Indian pharma

09/29/2013 | Business Standard (India)

Top Indian drugmakers say they need stricter compliance procedures and greater investment in quality to maintain their share in the global market amid concerns about increasing global enforcements. "Domestic companies represent a significant part of the global drug industry and, therefore, there is an increase in the scrutiny of these companies," Biocon Chairman and Managing Director Kiran Mazumdar-Shaw said. Audits are more frequent than earlier periodic reviews because of the U.S. FDA's presence in the country now, she said.

View Full Article in:

Business Standard (India)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
Catheter Engineer
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
MANAGER MEDICAL GAS COMPLIANCE AND SAFETY
Matheson Tri-Gas, Inc.
Houston, TX
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations